Cognex Corp · Healthcare · Measuring & Control Equipment
As of 2026-06-26, Cognex Corp (CGNX) has a 3-month relative strength percentile of 84 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 69. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.0%, relative volume 2.09×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 84, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
CGNX is in a stage 2 uptrend, week 3. Currently in a 22-day base; basing ADR 3.9% (broad 3.8%). VCP detected: inconclusive. RS line at new high since base start. Distance from 50d / 200d: 7.5% / 36.7%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CGNX is held by 12 ETFs as of Mar 2026. Top owner: IJH at 0.25% weight, $269M notional. Top 3 carry $714M.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJHiShares Core S&P Mid-Cap ETF | 0.25% | $269M |
| VTIVanguard Total Stock Market ETF | 0.01% | $258M |
| VBVanguard Small Cap ETF | 0.11% | $187M |
| VBKVanguard Small-Cap Growth ETF | 0.27% | $105M |
| VXFVanguard Extended Market ETF | 0.11% | $91M |
| MDYState Street SPDR S&P MIDCAP 400 ETF Trust | 0.25% | $61M |
| IWRiShares Russell Midcap ETF | 0.07% | $31M |
| IWDiShares Russell 1000 Value ETF | 0.03% | $19M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $10M |
| IWBiShares Russell 1000 ETF | 0.01% | $6M |
Showing 10 of 12 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CGNX Jan avg: 5.43% median: 9.47% win: 75% σ: 13.04% n: 4 2022-04-12 → 2026-05-29 | CGNX Feb avg: 4.60% median: -2.11% win: 50% σ: 26.64% n: 4 2022-04-12 → 2026-05-29 | CGNX Mar avg: -1.75% median: -2.28% win: 50% σ: 9.05% n: 4 2022-04-12 → 2026-05-29 | CGNX Apr avg: -1.33% median: -3.75% win: 20% σ: 8.52% n: 5 2022-04-12 → 2026-05-29 | CGNX May avg: 4.97% median: 9.78% win: 80% σ: 19.04% n: 5 2022-04-12 → 2026-05-29 | CGNX Jun avg: -0.42% median: 2.33% win: 75% σ: 8.02% n: 4 2022-04-12 → 2026-05-29 (current) | CGNX Jul avg: 13.01% median: 13.01% win: 75% σ: 13.86% n: 4 2022-04-12 → 2026-05-29 | CGNX Aug avg: -10.51% median: -15.60% win: 25% σ: 12.36% n: 4 2022-04-12 → 2026-05-29 | CGNX Sep avg: -2.01% median: -0.64% win: 50% σ: 5.57% n: 4 2022-04-12 → 2026-05-29 | CGNX Oct avg: -3.24% median: -4.65% win: 25% σ: 11.50% n: 4 2022-04-12 → 2026-05-29 | CGNX Nov avg: 0.97% median: 2.07% win: 50% σ: 6.87% n: 4 2022-04-12 → 2026-05-29 | CGNX Dec avg: -2.63% median: -5.46% win: 25% σ: 9.19% n: 4 2022-04-12 → 2026-05-29 |